Real-world evidence confirms the benefits of starting treatment in people with MS over 60 years of age, showing ocrelizumab effectively reduces relapses in this group.
MS Australia has today announced Ms Rachel Kerr as the recipient of the 2023 John Studdy Award in recognition of her commitment, dedication and service to people living with multiple sclerosis (MS).Â
MS Australia-supported researchers have developed a suite of free tools allowing MS researchers to apply standard definitions for clinical outcome measures.
We sat down with Des to discuss the three key areas he wishes to progress during his term as Chair, his plans for succession, and the motivation and thinking regarding his decision to serve only two years of the three-year term.
CEO Rohan Greenland talks about gearing up for his fourth May 50K and the two special people who help spur him on to lace up his runners and raise as much as he can to fuel MS research.
In the face of a 25-year odyssey with multiple sclerosis (MS), George stands as a testament to the power of resilience and optimism.
MS Australia sat down with Caro on The Raw Nerve podcast to discuss her publishing career , her love of books, the challenges she faced following her MS diagnosis, and how her father’s extraordinary positive example shaped her perspective on disability.
Researchers have embarked on a collaborative effort to identify key priorities for investigating women’s health issues in MS. This initiative provides a roadmap for future studies to address critical gaps in knowledge and improve care outcomes for women living with MS.
Searching for novel Genetic biomarkers to improve Multiple Sclerosis outcomes (GEMS)
